FIBROGEN
FibroGen was founded to discover, develop, and commercialize novel therapeutics that stop fibrosis, or pathological scarring, addressing unmet needs in fibrotic disorders affecting the major organs,...
www.fibrogeneurope.com/ View full profile
| |
Gaia Organics
Stuart Thomson is the Founder, Director, and Principal Researcher at the Gaia Research Institute, founded in 1990 and situated at the Garden of Eden, between Knysna and Plettenberg Bay, South Africa,...
www.gaiaresearch.co.za/ View full profile
| |
HemoCleanse, Inc.
HemoCleanse has an extensive history of research and product development of innovative medical technologies, particularly in sorbent-based extracorporeal therapies and vascular access systems for use...
www.hemocleanse.com/ View full profile
| |
iQur Ltd
iQur® is a specialty pharmaceutical company at the forefront of international breakthroughs in the detection, treatment and monitoring of Hepatitis C and other liver diseases.
iQur exists...
www.hepcgen.com/ View full profile
| |
Human BioSystems
Human BioSystems (OTC-BB:HBSC) was founded in February 1998 after more than ten years of research. We believe that our proposed technology represents a breakthrough in the storage and preservation of...
www.humanbiosystems.com/ View full profile
| |
HµREL Corporation
HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise...
www.hurelcorp.com/ View full profile
| |
Inotech Labor AG
The company owns a GMP production unit in Basel, where biopharmaceuticals are currently being developed and manufactured for use in clinical studies. These biopharmaceuticals are manufactured in...
www.inotech.ch/ View full profile
| |
Neural Intervention Technologies, Inc.
Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that...
www.neuralinterventions.com/ View full profile
| |
Novocell, Inc
Novocell’s goal is to develop a renewable source of specialized cells that can be used to treat chronic cellular diseases. To achieve this goal, Novocell is uniquely positioned to exploit human stem...
www.NOVOCELL.COM/ View full profile
| |
Novosom AG
Novosom AG has solved the major obstacle towards DNA therapeutics: Delivery of the therapeutic principle towards the cell interior. Novosom and its partners develop unique DNA based therapeutics in...
www.novosom.com/ View full profile
| |
Onconome, Inc.
Onconome is dedicated to the discovery, development and commercialization of innovative biomarkers for the early and accurate detection of prostate, colon, bladder and other forms of cancer, including...
www.onconome.com/ View full profile
| |
ORIDIS Biomed GmbH
ORIDIS™ Biomed is a biomedical company focusing on the discovery and development of therapeutics and targeted treatment solutions for liver cancer and metabolic diseases of the liver.ORIDIS™ Biomed...
www.oridis-biomed.com/ View full profile
| |
The Pelican Cancer Foundation
The Pelican Cancer Foundation is a unique charity, dedicated exclusively to curing cancer patients by advancing the latest techniques of precision surgery.The Charity derives its name from the words...
www.pelicancentre.com/ View full profile
| |
Puracyp, Inc.
Puracyp began operations in 1993 focusing on the distribution of monospecific inhibitory antibodies to several human P450 enzymes. Members of the pharmaceutical industry used these antibodies to...
www.puracyp.com/ View full profile
| |
RUBIN
By-products from Norwegian fisheries, included fish farming consist of viscera (liver, roe, stomachs, etc.), heads, backbones, cuts and rejected fish from processing. The by-products are generated...
www.rubin.no/ View full profile
| |
